Archives: Speakers

Kevin Tsai is a senior data and analytics leader with over 20 years of experience spanning biotechnology, data/software engineering, and data platforms with companies like Celera, Gilead, and Celgene / Bristol Myers Squibb. He currently leads enterprise data initiatives at Genmab, driving data-as-a-product, data mesh, and modern cloud-based data platforms. Kevin combines engineering expertise with strategic leadership, helping organizations transform complex data management across research, clinical development, and commercial functions. He is passionate about building high-performing teams, advancing data literacy, and creating scalable data ecosystems that accelerate innovation.

I lead R&D data enablement and data product strategy, building scalable, governed data foundations that transform data into a strategic asset across the Pharma R&D value chain. I focus on building high-quality, reusable, and interoperable operational data platforms and domain-specific data products that speed scientific outcomes, support advanced analytics and AI/ML, and deliver measurable business value. I work closely with stakeholders across Research, Clinical Development, Safety, Regulatory, and Portfolio & Project Management to ensure R&D data is discoverable, analytics-ready, and fit for decision-making. By applying data product thinking, strong governance, and modern data architecture principles, I help organizations move from siloed data to trusted, scalable, cross-domain insights. Core Competencies: R&D data foundations & data product strategy, Analytics- and AI/ML-ready data enablement, Data governance, Product Management, Clinical Data Management, Data Standards & Analytics, Decentralized Trials (DCT, DHT), Governance & Risk Oversight, AI & Digital Innovation, Stakeholder Management, Data Privacy & Security, Vendor Management, Design Thinking, Leadership Development, Certified Coach Technology, Tools, and Frameworks: Medidata Rave, Oracle Clinical, Veeva Clinical/Vault, Informatica, Reltio, Formedyx, Collibra, Python, VBA, Databricks, AWS Bedrock, UIPath, Redshift, SpotFire, Power BI, GCP, CDISC, 21CFRP11, RBQM, FHIR, CRISP-DM, V3+, LEAN

Broadly speaking, I am a research professional dedicated to improving access to healthcare services, the development of novel and effective treatments for disease prevention, symptom relief, and cures, and improving the quality of care through a reduction in the occurrence of medical errors. My particular set of skills, acquired through education and experience, have made me adept at working with the data essential to tackling these issues.

Strategic Clinical Development Leader | Oncology & Beyond I am a strategic and science-driven clinical development leader with 16+ years of experience shaping global drug development across oncology (solid tumors & hematologic malignancies), cardiovascular, rare, and specialty medicine. Over my career, I have:

• Directed global Phase I–III trials that informed pivotal approvals and label expansions
• Led NDA/BLA submissions resulting in successful global filings and regulatory milestones
• Built and guided high-performing cross-functional teams spanning Clinical Development, Biostatistics, Safety, Regulatory, and Clinical Operations
• Partnered with KOLs, CROs, and regulators to navigate complex development pathways I’m known for bringing clarity and structure to complexity, aligning science with strategy, and driving decisions that accelerate development while upholding patient focus and data integrity. As a senior leader, I thrive in fast-paced, matrixed environments where strategy, adaptability, and communication define success. I am also deeply committed to mentorship and talent development, ensuring teams grow alongside programs. Specialties: Oncology Clinical Development | Global Regulatory Submissions | Trial Oversight | Medical Monitoring | Portfolio & Pipeline Strategy | Cross-Functional Leadership | Data-Driven Decision Making

Experienced Consultant with a demonstrated history of delivering clinical IT projects for pharma, biotech/CROs with a Wharton Management Development Program, Kellogg Product Strategy and a Stanford Advanced Program Management from Stanford University. Anand is a tech savvy leader with interests in AI, big data, blockchain and use them to address the challenges faced by the life sciences industry. He is a big believer in product innovation and leads teams in product development. Anand loves participating in hackathons and social innovation activities in the life sciences/ healthcare space.

Alex Liu is the AD, Clinical Systems at Taiho Oncology, where he leads in‑house EDC study builds and advances data review capabilities to support high‑quality clinical trial execution. His work focuses on CRF standardization and the integration of AI‑driven approaches into scalable workflows that deliver earlier, more actionable insights. Alex drives initiatives to modernize clinical data management through advanced analytics and AI adoption, bridging technical innovation with business needs. He has a strong interest in the evolving role of AI in clinical research.

Amir Momen-Roknabadi is Director of Artificial Intelligence at Therna Biosciences, where he leads the AI team accelerating RNA design and optimization across the therapeutic pipeline. He brings over a decade of experience across machine learning, computational biology, and translational biotechnology, with deep expertise in building end-to-end ML systems that turn complex biological and clinical data into actionable insight.

Prior to Therna, Amir developed RNA-based generative AI models for early cancer detection at Exai Bio, contributing to liquid biopsy approaches validated against clinical cohorts. Amir earned his Ph.D. from Princeton University and completed postdoctoral training at Columbia University, where he developed computational methods to connect biological sequence, structure, and function at scale.

Dr. Abigail Casey holds a degree in Chemical and Life Science Engineering and serves as the Key Account Manager for Pharmaceutical Markets at Anton Paar USA, where she supports strategic pharmaceutical accounts through market development, customer engagement, and cross-functional collaboration.

Prior to joining Anton Paar, she held leadership roles in external manufacturing, applied technology, and product development, supporting projects from early-stage research through commercialization and global supply chain execution.

Dr. Casey has experience across R&D, formulation development, clinical support, technology transfer, manufacturing scale-up, and contract manufacturing management. Her background provides a unique perspective on how analytical characterization tools support pharmaceutical workflows from discovery through commercial production.

Dr. Andre Braun holds a degree in Physics and a doctorate from the Swiss Federal Institute of Technology (ETH Zurich), where his research focused on the rheology of complex biopolymer systems. Following his PhD, he joined the Technical University of Munich as a Senior Lecturer at the Chair of Process Systems Engineering, teaching rheology, process engineering, and numerical simulation while leading the rheology research group.

Since joining Anton Paar in 2016, Dr. Braun has held international roles in rheology product management and application development. As International Product Manager for Rheometry, he supports pharmaceutical, biotechnology, and other regulated industries in the application of rheological methods for formulation development, process optimization, quality control, and regulatory compliance.